STA Wealth Management LLC reduced its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 98.6% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,868 shares of the financial services provider’s stock after selling 133,636 shares during the period. STA Wealth Management LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $204,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in IBB. Global Trust Asset Management LLC increased its stake in iShares Nasdaq Biotechnology ETF by 89,733.3% in the 2nd quarter. Global Trust Asset Management LLC now owns 32,340 shares of the financial services provider’s stock valued at $32,000 after buying an additional 32,304 shares during the period. Meridian Wealth Management LLC bought a new position in iShares Nasdaq Biotechnology ETF in the first quarter valued at $36,000. Signaturefd LLC increased its stake in iShares Nasdaq Biotechnology ETF by 59.2% in the second quarter. Signaturefd LLC now owns 328 shares of the financial services provider’s stock valued at $36,000 after acquiring an additional 122 shares during the last quarter. Oakworth Capital Inc. boosted its position in iShares Nasdaq Biotechnology ETF by 171.4% during the second quarter. Oakworth Capital Inc. now owns 475 shares of the financial services provider’s stock valued at $52,000 after buying an additional 300 shares during the period. Finally, Advisory Alpha LLC purchased a new stake in iShares Nasdaq Biotechnology ETF during the first quarter valued at about $55,000. Hedge funds and other institutional investors own 77.82% of the company’s stock.

Shares of iShares Nasdaq Biotechnology ETF stock traded up $0.18 during trading on Tuesday, reaching $105.32. 90,269 shares of the stock were exchanged, compared to its average volume of 2,011,876. The stock’s fifty day moving average is $103.98 and its 200 day moving average is $106.71. iShares Nasdaq Biotechnology ETF has a 1 year low of $89.01 and a 1 year high of $122.97.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Cost of Equity For A Business, Investors

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.